bone loss semaglutide With the growing use of weight-loss medications, many people are asking an important question: What impact do weight-loss drugs have on and muscle? This helpful blog post from the National Osteoporosis Weight loss induced bone loss:

Anal Lett 40:25062514

Conversely, GLP-1 receptor agonists inhibit AgRP/NPY neurons through a mechanism involving enhanced presynaptic GABAergic input mediated by both TRPC5 and K_ATP channels, and an indirect suppression of excitatory glutamatergic input via polysynaptic circuits [11]

The data also showed that 6 per cent of those polled said they were currently using a GLP-1 drug, such as Novo Nordisk's diabetes drug Ozempic or weight-loss treatment Wegovy, or Eli Lilly's obesity drug Zepbound

Not all weight loss is equal

Peptides are short chains of amino acids that act as signals, instructing your body to carry out specific functions, such as growth hormone release